UBS Group’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.26M Buy
855,302
+527,887
+161% +$2.01M ﹤0.01% 3421
2025
Q1
$861K Sell
327,415
-709,864
-68% -$1.87M ﹤0.01% 4304
2024
Q4
$3.67M Buy
1,037,279
+1,017,775
+5,218% +$3.6M ﹤0.01% 3239
2024
Q3
$88.9K Buy
19,504
+10,734
+122% +$48.9K ﹤0.01% 5253
2024
Q2
$38.2K Sell
8,770
-25,464
-74% -$111K ﹤0.01% 5748
2024
Q1
$172K Buy
34,234
+4,739
+16% +$23.8K ﹤0.01% 4807
2023
Q4
$185K Buy
29,495
+14,963
+103% +$93.8K ﹤0.01% 4642
2023
Q3
$103K Sell
14,532
-2,165
-13% -$15.4K ﹤0.01% 4703
2023
Q2
$170K Buy
+16,697
New +$170K ﹤0.01% 4559
2023
Q1
Sell
-3,090
Closed -$22.2K 8952
2022
Q4
$22.2K Buy
+3,090
New +$22.2K ﹤0.01% 6373
2022
Q3
Sell
-2,152
Closed -$10K 9625
2022
Q2
$10K Buy
2,152
+1,152
+115% +$5.35K ﹤0.01% 6954
2022
Q1
$6K Sell
1,000
-1,253
-56% -$7.52K ﹤0.01% 7935
2021
Q4
$11K Buy
2,253
+1,410
+167% +$6.88K ﹤0.01% 7560
2021
Q3
$6K Buy
843
+139
+20% +$989 ﹤0.01% 7292
2021
Q2
$4K Sell
704
-1,680
-70% -$9.55K ﹤0.01% 7579
2021
Q1
$16K Buy
2,384
+661
+38% +$4.44K ﹤0.01% 6554
2020
Q4
$9K Buy
1,723
+992
+136% +$5.18K ﹤0.01% 6545
2020
Q3
$5K Sell
731
-1,014
-58% -$6.94K ﹤0.01% 6449
2020
Q2
$13K Buy
1,745
+1,403
+410% +$10.5K ﹤0.01% 5990
2020
Q1
$3K Sell
342
-1,439
-81% -$12.6K ﹤0.01% 6589
2019
Q4
$10K Buy
+1,781
New +$10K ﹤0.01% 6214
2019
Q3
Sell
-4,211
Closed -$13K 7139
2019
Q2
$13K Buy
4,211
+1,551
+58% +$4.79K ﹤0.01% 6030
2019
Q1
$8K Sell
2,660
-19,082
-88% -$57.4K ﹤0.01% 6114
2018
Q4
$82K Buy
21,742
+19,915
+1,090% +$75.1K ﹤0.01% 4824
2018
Q3
$11K Buy
1,827
+156
+9% +$939 ﹤0.01% 6197
2018
Q2
$9K Buy
+1,671
New +$9K ﹤0.01% 6274
2018
Q1
Sell
-1,108
Closed -$13K 7041
2017
Q4
$13K Buy
+1,108
New +$13K ﹤0.01% 5899